📣 VC round data is live. Check it out!
- Public Comps
- Eurobio Scientific
Eurobio Scientific Valuation Multiples
Discover revenue and EBITDA valuation multiples for Eurobio Scientific and similar public comparables like Carvolix, Median Technologies, Quantum-Si, Australian Clinical Labs and more.
Eurobio Scientific Overview
About Eurobio Scientific
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
Founded
2018
HQ

Employees
127
Website
Financials (LTM)
EV
$252M
Valuation Multiples
Start free trialEurobio Scientific Financials
Eurobio Scientific reported last 12-month revenue of $200M and EBITDA of $35M.
In the same LTM period, Eurobio Scientific generated $35M in EBITDA and $11M in net income.
Revenue (LTM)
Eurobio Scientific P&L
In the most recent fiscal year, Eurobio Scientific reported revenue of $197M and EBITDA of $32M.
Eurobio Scientific is profitable as of last fiscal year, with gross margin of 45%, EBITDA margin of 16%, and net margin of 5%.
Financial data powered by Morningstar, Inc.
Eurobio Scientific Stock Performance
Eurobio Scientific has current market cap of $258M, and enterprise value of $252M.
Market Cap Evolution
Eurobio Scientific's stock price is $25.60.
Eurobio Scientific share price increased by 0.7% in the last 30 days, and decreased by 12.1% in the last year.
Eurobio Scientific has an EPS (earnings per share) of $0.93.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $252M | $258M | 0.8% | 0.7% | 5.2% | -12.1% | $0.93 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEurobio Scientific Valuation Multiples
Eurobio Scientific trades at 1.3x EV/Revenue multiple, and 7.3x EV/EBITDA.
EV / Revenue (LTM)
Eurobio Scientific Financial Valuation Multiples
As of June 4, 2026, Eurobio Scientific has market cap of $258M and EV of $252M.
Eurobio Scientific has a P/E ratio of 23.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Eurobio Scientific Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Eurobio Scientific Margins & Growth Rates
Eurobio Scientific grew revenue by 4% and EBITDA by 16% in the last fiscal year.
In the most recent fiscal year, Eurobio Scientific reported gross margin of 45%, EBITDA margin of 16%, and net margin of 5%.
Eurobio Scientific Margins
Eurobio Scientific Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Eurobio Scientific Operational KPIs
Eurobio Scientific's revenue per employee in the last FY averaged $1.6M, while opex per employee averaged $0.6M for the same period.
Eurobio Scientific's Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Eurobio Scientific's Rule of X is 29% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Eurobio Scientific Competitors
Eurobio Scientific competitors include Carvolix, Median Technologies, Quantum-Si, Australian Clinical Labs, Dong-A ST, Stratec, OraSure, Carlsmed, Profound Medical and Affluent Medical.
Most Eurobio Scientific public comparables operate across Laboratory Services, Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 57.0x | 401.8x | (19.6x) | (12.8x) | |||
| 9.3x | 8.8x | (13.7x) | (13.8x) | |||
| 58.8x | 77.6x | (1.8x) | (1.7x) | |||
| 0.9x | 0.9x | 3.5x | 3.4x | |||
| 0.8x | 0.8x | 11.0x | 10.4x | |||
| 1.3x | 1.2x | 9.1x | 8.7x | |||
| 1.0x | 0.9x | (2.7x) | (2.7x) | |||
| 3.9x | 3.2x | (7.1x) | (6.4x) | |||
This data is available for Pro users. Sign up to see all Eurobio Scientific competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Eurobio Scientific
| When was Eurobio Scientific founded? | Eurobio Scientific was founded in 2018. |
| Where is Eurobio Scientific headquartered? | Eurobio Scientific is headquartered in France. |
| How many employees does Eurobio Scientific have? | As of today, Eurobio Scientific has over 127 employees. |
| Is Eurobio Scientific publicly listed? | Yes, Eurobio Scientific is a public company listed on Euronext Paris. |
| What is the stock symbol of Eurobio Scientific? | Eurobio Scientific trades under ALERS ticker. |
| When did Eurobio Scientific go public? | Eurobio Scientific went public in 2005. |
| Who are competitors of Eurobio Scientific? | Eurobio Scientific main competitors include Carvolix, Median Technologies, Quantum-Si, Australian Clinical Labs, Dong-A ST, Stratec, OraSure, Carlsmed, Profound Medical, Affluent Medical. |
| What is the current market cap of Eurobio Scientific? | Eurobio Scientific's current market cap is $258M. |
| What is the current revenue of Eurobio Scientific? | Eurobio Scientific's last 12 months revenue is $200M. |
| What is the current revenue growth of Eurobio Scientific? | Eurobio Scientific revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Eurobio Scientific? | Current revenue multiple of Eurobio Scientific is 1.3x. |
| What is the current EBITDA of Eurobio Scientific? | Eurobio Scientific's last 12 months EBITDA is $35M. |
| What is Eurobio Scientific's EBITDA margin? | Eurobio Scientific's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Eurobio Scientific? | Current EBITDA multiple of Eurobio Scientific is 7.3x. |
| What is the current FCF of Eurobio Scientific? | Eurobio Scientific's last 12 months FCF is $23M. |
| What is Eurobio Scientific's FCF margin? | Eurobio Scientific's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Eurobio Scientific? | Current FCF multiple of Eurobio Scientific is 11.0x. |
| How many companies Eurobio Scientific has acquired to date? | Eurobio Scientific hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Eurobio Scientific has invested to date? | Eurobio Scientific hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Eurobio Scientific
Lists including Eurobio Scientific
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.